Diabetes status from HbA1c is determined by measuring glycated haemoglobin in the blood, providing a reliable picture of average glucose levels over the preceding two to three months. In the UK, results are reported in mmol/mol and fall into three clinically significant categories: normal, non-diabetic hyperglycaemia (prediabetes), or consistent with type 2 diabetes. Understanding what your HbA1c result means, how NHS and NICE guidelines apply, and what steps to take next is essential for managing your health proactively. This article explains the diagnostic thresholds, factors that can affect accuracy, and when to seek further medical advice.

What HbA1c Levels Mean for Diabetes Diagnosis in the UK

In the UK, an HbA1c below 42 mmol/mol is normal, 42–47 mmol/mol indicates non-diabetic hyperglycaemia, and 48 mmol/mol or above is consistent with type 2 diabetes. A single raised result in an asymptomatic person requires confirmation with a repeat test.

HbA1c, or glycated haemoglobin, is a blood test that reflects average blood glucose levels over the preceding two to three months. When glucose circulates in the bloodstream, it binds to haemoglobin — the protein inside red blood cells — and the resulting compound is measured as HbA1c. Because red blood cells have a lifespan of approximately 120 days, this test provides a reliable snapshot of longer-term glucose control. The result is weighted towards the most recent four to six weeks, rather than reflecting a single moment in time.

In the UK, HbA1c results are reported in millimoles per mole (mmol/mol), following international standardisation. Some patients may also see a percentage figure (%) on older reports or patient information materials; for reference, the key diagnostic threshold of 48 mmol/mol corresponds to 6.5%. The result is used to classify an individual's glucose status into one of three broad categories:

• Below 42 mmol/mol — considered within the normal range, suggesting no current evidence of impaired glucose regulation

• 42–47 mmol/mol — classified as non-diabetic hyperglycaemia (sometimes referred to as prediabetes), indicating elevated risk of developing type 2 diabetes

• 48 mmol/mol or above — consistent with a diagnosis of type 2 diabetes, provided clinical criteria are met

It is important to understand that HbA1c is a diagnostic and monitoring tool, not a definitive standalone verdict. A single raised result in a person without symptoms typically requires confirmation with a repeat test before a formal diagnosis is made. Clinicians interpret HbA1c results alongside the individual's clinical history, symptoms, and other relevant investigations to reach an accurate assessment of diabetes status.

HbA1c is not suitable for diagnosing diabetes in all circumstances. It should not be used as the primary diagnostic test in children and young people, in those with suspected type 1 diabetes, during pregnancy or the postpartum period, in people with haemoglobinopathies or conditions affecting red blood cell turnover, or in those who are acutely unwell. In these situations, fasting plasma glucose or an oral glucose tolerance test (OGTT) is preferred. Further detail is provided in the section on factors affecting HbA1c results.

NICE and NHS Guidelines on HbA1c Thresholds

NICE guideline NG28 recommends a single HbA1c of 48 mmol/mol or above to diagnose type 2 diabetes in symptomatic individuals, or two separate readings in those without symptoms. Those in the 42–47 mmol/mol range should receive lifestyle advice and referral to the NHS Diabetes Prevention Programme.

The National Institute for Health and Care Excellence (NICE) and NHS England have established clear, evidence-based thresholds for interpreting HbA1c results in the context of type 2 diabetes diagnosis and risk stratification. These guidelines are set out in NICE guideline NG28 (Type 2 diabetes in adults: management) and align with WHO 2011 guidance on the use of HbA1c for diagnosis.

According to NICE guidance, a diagnosis of type 2 diabetes can be made on the basis of a single HbA1c result of 48 mmol/mol or above in a symptomatic individual. In those without symptoms, two separate readings of 48 mmol/mol or above are required to confirm the diagnosis. This two-test requirement helps minimise the risk of misdiagnosis due to transient elevation or laboratory variation.

For individuals identified in the non-diabetic hyperglycaemia range (42–47 mmol/mol), NICE recommends:

• Lifestyle intervention as the primary management strategy, including dietary modification, increased physical activity, and weight management where appropriate

• Annual HbA1c monitoring to track progression or regression, though clinicians may arrange a repeat test sooner (within three to six months) if the result is close to the 48 mmol/mol threshold or if multiple risk factors are present

• Referral to the NHS Diabetes Prevention Programme (NHS DPP) in England — a structured, evidence-based behavioural intervention that has been shown to reduce the risk of progression to type 2 diabetes. Equivalent structured prevention programmes are available in Scotland, Wales, and Northern Ireland through their respective health services.

NICE also specifies that HbA1c should not be used as the sole diagnostic criterion in certain populations where its reliability may be compromised. These include children and young people, individuals with suspected type 1 diabetes, pregnant women and those in the postpartum period, people with haemoglobinopathies or significant anaemia, those with advanced chronic kidney disease or on renal replacement therapy, individuals who have recently received a blood transfusion, and those who are acutely unwell or on high-dose corticosteroids. In such cases, fasting plasma glucose or an OGTT is more appropriate. Clinicians are advised to use clinical judgement alongside these thresholds rather than applying them rigidly in isolation.

Factors That Can Affect HbA1c Results and Interpretation

HbA1c can be falsely lowered by haemolytic anaemia, recent blood transfusion, and pregnancy, and falsely raised by iron-deficiency anaemia or vitamin B12 deficiency. In these circumstances, fasting plasma glucose or an OGTT is the preferred diagnostic test.

Whilst HbA1c is a robust and widely validated test, several physiological, haematological, and demographic factors can influence its accuracy. Understanding these limitations is essential for both clinicians and patients when interpreting results.

Conditions that may falsely lower HbA1c:

• Haemolytic anaemia and other conditions that shorten red blood cell lifespan — fewer older cells means less glycated haemoglobin is measured, potentially underestimating true glucose exposure

• Recent blood transfusion or acute blood loss, which introduces new red blood cells

• Pregnancy, particularly in the second and third trimesters, due to increased red cell turnover

• Use of erythropoiesis-stimulating agents (EPO therapy)

Conditions that may falsely raise HbA1c:

• Iron-deficiency anaemia — reduced red cell turnover leads to older, more glycated cells, which can produce a spuriously elevated HbA1c result. It is important to note that HbA1c may fall after iron replacement, and results should be interpreted with caution in this context

• Vitamin B12 or folate deficiency

Conditions where HbA1c may be unreliable in either direction:

• Haemoglobin variants (such as sickle cell trait, haemoglobin C, or other haemoglobinopathies) can cause spuriously high or low results depending on the laboratory assay method used. Laboratories should use NGSP/IFCC-aligned methods and consult assay interference tables when haemoglobin variants are known or suspected

• Advanced chronic kidney disease (CKD) and end-stage renal disease (ESRD) — HbA1c is often lower than expected in advanced CKD due to reduced red cell lifespan and the use of EPO therapy, but the direction of bias can vary by assay and clinical context. HbA1c should be considered unreliable for diagnostic purposes in this group; fasting plasma glucose or OGTT is preferred

In all of the above circumstances, HbA1c should not be used as the primary diagnostic test. Alternative glucose measurements should be arranged and results interpreted in the context of the full clinical picture.

Ethnicity may also play a role. Some studies suggest that individuals of South Asian, African, or African-Caribbean descent may have slightly higher HbA1c values independent of blood glucose levels, though the clinical significance of this remains an area of ongoing research and no official adjustment is recommended in current UK guidelines.

Age is another consideration — HbA1c tends to rise modestly with age even in the absence of diabetes. Clinicians should therefore interpret borderline results with care, particularly in older adults, and consider complementary investigations where clinical uncertainty exists.

Next Steps After Receiving Your HbA1c Result

Next steps depend on the result category: normal results may require periodic rescreening if risk factors are present, prediabetes warrants lifestyle intervention and annual monitoring, and a confirmed type 2 diabetes result triggers a structured care plan including education, medication review, and ongoing monitoring.

Receiving an HbA1c result can feel daunting, but understanding what it means and what happens next can help individuals take informed, constructive action. The appropriate next steps depend on which category the result falls into.

If your result is below 42 mmol/mol (normal range): No immediate action is required from a diabetes perspective. However, if you have risk factors for type 2 diabetes — such as obesity, a family history of diabetes, or a history of gestational diabetes — your GP may recommend periodic rescreening, typically every one to three years.

If your result is in the non-diabetic hyperglycaemia range (42–47 mmol/mol): This is an important opportunity for preventive action. Your GP or practice nurse is likely to:

• Discuss lifestyle modifications, including a balanced diet lower in refined carbohydrates and added sugars, regular moderate-intensity physical activity (at least 150 minutes per week), and weight loss if indicated

• Refer you to the NHS Diabetes Prevention Programme (in England) or an equivalent structured prevention programme in your nation

• Arrange a repeat HbA1c in approximately 12 months, or sooner if your result is close to 48 mmol/mol or you have several risk factors

If your result is 48 mmol/mol or above (consistent with type 2 diabetes): A repeat confirmatory test will usually be arranged unless you are symptomatic. Once confirmed, your GP will initiate a structured care plan in line with NICE NG28. This typically includes:

• Dietary advice and support with lifestyle change

• Referral to a structured diabetes education programme, such as DESMOND or X-PERT, which provides practical skills for self-management

• Consideration of medication — metformin is the recommended first-line oral glucose-lowering agent, which works by reducing hepatic glucose production and improving insulin sensitivity. Your GP will discuss whether medication is appropriate for you and agree an individual HbA1c target

• Ongoing monitoring, including blood pressure and cholesterol management, annual foot screening, retinal (eye) screening, kidney function checks (eGFR and urine albumin-to-creatinine ratio), and relevant vaccinations

• Regular HbA1c monitoring — typically every three to six months until stable, then every six months

In all cases, patients are encouraged to engage actively with their healthcare team and ask questions about their results and management options.

When to Seek Further Assessment or GP Advice

Contact your GP promptly if you experience excessive thirst, frequent urination, unexplained fatigue, or slow-healing wounds, as these may indicate undiagnosed or poorly controlled diabetes. Call 999 immediately if symptoms suggest diabetic ketoacidosis, such as vomiting, rapid breathing, or confusion.

Knowing when to seek prompt medical advice is an important aspect of managing diabetes risk or a new diagnosis. Whilst HbA1c is a routine test, certain circumstances warrant timely contact with your GP or healthcare provider.

Contact your GP promptly if you experience any of the following symptoms, which may suggest significantly elevated blood glucose levels:

• Excessive thirst or a dry mouth that does not resolve

• Frequent urination, particularly at night

• Unexplained fatigue or lethargy

• Blurred vision

• Slow-healing wounds or recurrent infections

• Unintentional weight loss

These symptoms, particularly in combination, may indicate undiagnosed or poorly controlled diabetes and should not be attributed to other causes without proper assessment.

Seek emergency care (call 999 or go to A&E immediately) if you or someone else develops any of the following, as these may indicate diabetic ketoacidosis (DKA) or a hyperglycaemic emergency:

• Abdominal pain, nausea, or vomiting

• Rapid or deep breathing

• Drowsiness, confusion, or difficulty staying awake

• A fruity or acetone smell on the breath

• Collapse or loss of consciousness

DKA is a medical emergency most commonly associated with type 1 diabetes but can occur in other circumstances. Do not wait for a GP appointment if these features are present.

If type 1 diabetes is suspected — for example, in a younger person with rapid onset of symptoms, significant unintentional weight loss, or ketonuria — same-day specialist assessment is required. HbA1c is not appropriate for diagnosing type 1 diabetes; urgent blood glucose and ketone testing should be arranged without delay. If you are unsure, contact NHS 111 for guidance.

You should also seek further assessment if:

• Your HbA1c result has been flagged as borderline and you have not received a clear explanation or follow-up plan

• You have a known condition (such as a haemoglobinopathy, haemolytic anaemia, or advanced chronic kidney disease) that may affect the reliability of your HbA1c result — your GP may arrange alternative glucose tests

• You are pregnant or planning a pregnancy, as diabetes screening and management in pregnancy follows a separate, more intensive pathway under NICE guideline NG3 (Diabetes in pregnancy)

• You have a strong family history of type 1 diabetes and are concerned about autoimmune diabetes, which requires different investigation and management

If you have already been diagnosed with type 2 diabetes and your HbA1c remains persistently above your agreed target despite lifestyle changes and medication, this should prompt a medication review with your GP or diabetes specialist nurse. Regular HbA1c monitoring is a cornerstone of ongoing diabetes management in the UK.

Frequently Asked Questions